Leave Your Message
NGP Was Honored as One of the Top 100 Enterprises in China's Pharmaceutical Industry in 2023

News

NGP Was Honored as One of the Top 100 Enterprises in China's Pharmaceutical Industry in 2023

2024-12-04

NGP Was Honored as One of the Top 100 Enterprises in China's Pharmaceutical Industry in 202304.jpg

 

September 6-9, 2024 by the China Pharmaceutical Industry Information Center hosted the “2024 (41st) annual meeting of the national pharmaceutical industry information and the 2023 annual conference of China's top 100 pharmaceutical industry list” was held in Chengdu. Mr. Li Wenqing, Vice Governor of Sichuan Provincial People's Government, attended the conference and delivered a speech; relevant leaders of the National Health Commission and the State Drug Administration made a keynote report; experts and entrepreneurs from industry, academia, research, medicine, application and gold gathered together to talk about the deep integration of the pharmaceutical industry and the whole chain of innovation ecology.

 

NGP Was Honored as One of the Top 100 Enterprises in China's Pharmaceutical Industry in 202301.jpg


In the afternoon of September 7, 2023 China Pharmaceutical Industry Top 100 list conference, the grand unveiling of the “2023 China Pharmaceutical Industry Top 100 Enterprises” list, NGP successfully selected, ranked 77th on the China Pharmaceutical Industry Top 100 list, and became the first local enterprise in Pengzhou to advance to the China Pharmaceutical Industry Top 100 list.

 

NGP Was Honored as One of the Top 100 Enterprises in China's Pharmaceutical Industry in 202302.jpg


Looking back at the list of the top 100 in the past 10 years, there were 164 enterprises on the list of the top 100 between 2014 and 2023, of which 56 enterprises have been on the list for 10 consecutive years, and enterprises on the list for more than 5 times accounted for 85.6% of the total number of times on the list. This fully demonstrates that the pattern of head enterprises in China's pharmaceutical industry has generally stabilized. It is worth noting that compared with 2022, 11 enterprises fell out of the top 100 in 2023. Nearly two-thirds of these enterprises are mainly engaged in the production of products related to the prevention and control of the new crown epidemic, which reflects the rapidly changing market environment and the intensity of competition. Against this backdrop, NGP has been able to stand out thanks to its strong comprehensive strength and the wise leadership of our Board Chairman, Mr. Zhou Housheng, who has been steadfastly following new concepts, new ideas and new methods, and steadily marching on the path of development of the new green circular economy.

 

NGP Was Honored as One of the Top 100 Enterprises in China's Pharmaceutical Industry in 202303.jpg